Announcements & Media

BARDA’s hub for the latest updates in medical countermeasure development, public health preparedness and pandemic response

EXPLORE ARTICLES

SAVE THE DATE:  BARDA Industry Day - November 3-4, 2021
EVENTS/MEETINGS
November 03, 2021
SAVE THE DATE: BARDA Industry Day - November 3-4, 2021
BARDA Industry Day 2021 Save the Date: November 3-4, 2021 - Virtual Event
WEB ANNOUNCEMENTS
May 14, 2021
BARDA Industry Day 2021 Save the Date: November 3-4, 2021 - Virtual Event
Seeking Proposals: Antibacterial Accelerator Broad Agency Announcement Special Instructions
WEB ANNOUNCEMENTS
May 13, 2021
Seeking Proposals: Antibacterial Accelerator Broad Agency Announcement Special Instructions
BARDA and AgileMD partner to deploy electronic health record integrated software tool for rapid and early identification of COVID-19 patients in need of emergency interventions
WEB ANNOUNCEMENTS
May 05, 2021
BARDA and AgileMD partner to deploy electronic health record integrated software tool for rapid and early identification of COVID-19 patients in need of emergency interventions
BARDA and PeraHealth partner to develop machine learning app to aid in assessments and triage of COVID-19 patients in the Emergency Department
WEB ANNOUNCEMENTS
May 05, 2021
BARDA and PeraHealth partner to develop machine learning app to aid in assessments and triage of COVID-19 patients in the Emergency Department
VIDEOS
May 04, 2021
BARDA Vaccine Market Research Workshop
Message from the Director: 3 BARDA scientists recognized for their contributions to Ebola control
WEB ANNOUNCEMENTS
May 03, 2021
Message from the Director: 3 BARDA scientists recognized for their contributions to Ebola control
May 03, 2021
Combatting COVID-19 Vaccine Hesitancy
BARDA and Enalare Therapeutics announce partnership to advance ENA-001 as an emergency treatment for opioid-induced respiratory depression in the community setting
WEB ANNOUNCEMENTS
April 23, 2021
BARDA and Enalare Therapeutics announce partnership to advance ENA-001 as an emergency treatment for opioid-induced respiratory depression in the community setting
April 08, 2021
Innovation challenge seeks to solve a common hurdle in curbing coronavirus spread: mask design
BARDA and the Janssen Pharmaceutical Companies of Johnson & Johnson expand Phase 2a COVID-19 vaccine trial to include adolescent population
WEB ANNOUNCEMENTS
April 02, 2021
BARDA and the Janssen Pharmaceutical Companies of Johnson & Johnson expand Phase 2a COVID-19 vaccine trial to include adolescent population
BARDA and Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) Awards $53.7 Million Contract to Ortho Clinical Diagnostics
WEB ANNOUNCEMENTS
April 01, 2021
BARDA and Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) Awards $53.7 Million Contract to Ortho Clinical Diagnostics
News Release from PHE.gov: HHS launches $500,000 contest for design of new, effective, comfortable, masks designed for general public use
WEB ANNOUNCEMENTS
March 31, 2021
News Release from PHE.gov: HHS launches $500,000 contest for design of new, effective, comfortable, masks designed for general public use
BARDA and FirstString Research announce partnership to repurpose aCT1 eye drops as a medical countermeasure against mustard gas keratopathy
WEB ANNOUNCEMENTS
March 30, 2021
BARDA and FirstString Research announce partnership to repurpose aCT1 eye drops as a medical countermeasure against mustard gas keratopathy
BARDA expands partnership with DiaSorin SpA to develop automated antigen detection assay for acute COVID-19
WEB ANNOUNCEMENTS
March 29, 2021
BARDA expands partnership with DiaSorin SpA to develop automated antigen detection assay for acute COVID-19
BARDA partners with NCATS to seek submissions for the development of advanced microphysiological immune tissue platforms through its new DRIVe ImmuneChip+ program
WEB ANNOUNCEMENTS
March 15, 2021
BARDA partners with NCATS to seek submissions for the development of advanced microphysiological immune tissue platforms through its new DRIVe ImmuneChip+ program
BARDA Vaccines Against AMR Threats Workshop
EVENTS/MEETINGS
March 12, 2021
BARDA Vaccines Against AMR Threats Workshop
BARDA and ContraFect partner to develop an antibacterial to treat Staphylococcus aureus bacteremia
WEB ANNOUNCEMENTS
March 12, 2021
BARDA and ContraFect partner to develop an antibacterial to treat Staphylococcus aureus bacteremia
BARDA and MediciNova, Inc. partner to repurpose MN-166 (ibudilast) as a medical countermeasure against chlorine exposure
WEB ANNOUNCEMENTS
March 09, 2021
BARDA and MediciNova, Inc. partner to repurpose MN-166 (ibudilast) as a medical countermeasure against chlorine exposure
News Release from HHS.gov: Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines
WEB ANNOUNCEMENTS
March 03, 2021
News Release from HHS.gov: Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines
BARDA expands partnership with Hologic for development of a fourth high-throughput molecular assay for SARS-CoV-2
WEB ANNOUNCEMENTS
March 02, 2021
BARDA expands partnership with Hologic for development of a fourth high-throughput molecular assay for SARS-CoV-2
 NEWS RELEASE FROM PHE.GOV: Biden Administration secures supply of new COVID-19 therapeutic treatment
WEB ANNOUNCEMENTS
March 02, 2021
NEWS RELEASE FROM PHE.GOV: Biden Administration secures supply of new COVID-19 therapeutic treatment
BARDA partners with LightDeck Diagnostics to develop a rapid, in vitro, point-of-care SARS-CoV-2 antigen test to detect SARS-CoV-2 infection
WEB ANNOUNCEMENTS
March 01, 2021
BARDA partners with LightDeck Diagnostics to develop a rapid, in vitro, point-of-care SARS-CoV-2 antigen test to detect SARS-CoV-2 infection
VIDEOS
March 01, 2021
Statement: BARDA director on emergency use authorization of the third COVID-19 vaccine
News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine
WEB ANNOUNCEMENTS
February 27, 2021
News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine
VIDEOS
February 25, 2021
#ASKBARDA - What does it mean when a clinical trial is paused?
VIDEOS
February 25, 2021
#ASKBARDA - Can you walk us through how clinical trial protocols have safety measures built in?
VIDEOS
February 25, 2021
#ASKBARDA - When a clinical trial is paused, or stopped, is that planned?
VIDEOS
February 25, 2021
#ASKBARDA - Why can't we know if the trial participant received the actual product or the placebo?
VIDEOS
February 25, 2021
#ASKBARDA - What is an independent Data Safety Monitoring Board (DSMB)?
VIDEOS
February 25, 2021
#ASKBARDA - What are some possible outcomes after the Data Safety Monitoring Board meets?
BARDA and Luminex Corporation collaborate on a single, rapid diagnostic test to distinguish coronavirus from influenza and RSV infections
WEB ANNOUNCEMENTS
February 19, 2021
BARDA and Luminex Corporation collaborate on a single, rapid diagnostic test to distinguish coronavirus from influenza and RSV infections
NEWS RELEASE FROM HHS.GOV: Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna
WEB ANNOUNCEMENTS
February 11, 2021
NEWS RELEASE FROM HHS.GOV: Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna
VIDEOS
February 09, 2021
BARDA COVID-19 Response: Dr. Robert Johnson, BARDA IEIDD Division Director and BARDA COVID-19 Response Lead
BARDA and Visby Medical partner to develop a rapid, hand-held, point-of-care and over-the-counter in vitro diagnostic test for influenza A/B and SARS-CoV-2.
WEB ANNOUNCEMENTS
February 02, 2021
BARDA and Visby Medical partner to develop a rapid, hand-held, point-of-care and over-the-counter in vitro diagnostic test for influenza A/B and SARS-CoV-2.
VIDEOS
January 21, 2021
BARDA DRIVe Program
BARDA, DOD, increase number of Lilly’s COVID-19 therapeutic treatment courses that can be purchased under agreement
WEB ANNOUNCEMENTS
January 13, 2021
BARDA, DOD, increase number of Lilly’s COVID-19 therapeutic treatment courses that can be purchased under agreement
BARDA and DiaSorin Molecular LLC collaborate on SARS-CoV-2 diagnostic test to distinguish coronavirus from influenza infections
WEB ANNOUNCEMENTS
January 13, 2021
BARDA and DiaSorin Molecular LLC collaborate on SARS-CoV-2 diagnostic test to distinguish coronavirus from influenza infections
NEWS RELEASE FROM PHE.GOV: HHS, DOD purchase additional doses of Regeneron’s antibody therapeutic to treat patients with mild to moderate COVID-19
WEB ANNOUNCEMENTS
January 12, 2021
NEWS RELEASE FROM PHE.GOV: HHS, DOD purchase additional doses of Regeneron’s antibody therapeutic to treat patients with mild to moderate COVID-19
 BARDA DRIVe and NIOSH seek expert input on criteria for upcoming mask innovation challenge
WEB ANNOUNCEMENTS
January 07, 2021
BARDA DRIVe and NIOSH seek expert input on criteria for upcoming mask innovation challenge
Message from the BARDA Director: Thanks for supporting BARDA in 2020
WEB ANNOUNCEMENTS
December 30, 2020
Message from the BARDA Director: Thanks for supporting BARDA in 2020
News release from HHS.Gov: HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
WEB ANNOUNCEMENTS
December 23, 2020
News release from HHS.Gov: HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
News Release from HHS.gov: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
WEB ANNOUNCEMENTS
December 23, 2020
News Release from HHS.gov: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
BARDA announces the 57th FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships
WEB ANNOUNCEMENTS
December 21, 2020
BARDA announces the 57th FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships
News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine
WEB ANNOUNCEMENTS
December 18, 2020
News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine
NEWS RELEASE FROM HHS.GOV: HHS, DOD engage Quantum Leap Healthcare Collaborative in search for effective treatments for the sickest COVID-19 patients
WEB ANNOUNCEMENTS
December 15, 2020
NEWS RELEASE FROM HHS.GOV: HHS, DOD engage Quantum Leap Healthcare Collaborative in search for effective treatments for the sickest COVID-19 patients
News Release from HHS.GOV: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
WEB ANNOUNCEMENTS
December 11, 2020
News Release from HHS.GOV: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
The Global Health Technologies Coalition 2020 Innovating for Impact Partnership award recognizes CARB-X for its work to transform breakthrough scientific research into lifesaving drugs, diagnostics, vaccines, and other products to combat antibiotic-resistant bacteria.
WEB ANNOUNCEMENTS
December 08, 2020
The Global Health Technologies Coalition 2020 Innovating for Impact Partnership award recognizes CARB-X for its work to transform breakthrough scientific research into lifesaving drugs, diagnostics, vaccines, and other products to combat antibiotic-resistant bacteria.
VIDEOS
December 08, 2020
CARB-X: 2020 Partnership Award
BARDA and Chembio Diagnostics collaborate on two rapid point-of-care diagnostic  tests to both detect antigens for COVID-19 and detect and differentiate Influenza from COVID-19.
WEB ANNOUNCEMENTS
December 03, 2020
BARDA and Chembio Diagnostics collaborate on two rapid point-of-care diagnostic tests to both detect antigens for COVID-19 and detect and differentiate Influenza from COVID-19.
BARDA DRIVe seeking interested applicants for the Early Notification to Act, Control, and Treat (ENACT) program
WEB ANNOUNCEMENTS
December 02, 2020
BARDA DRIVe seeking interested applicants for the Early Notification to Act, Control, and Treat (ENACT) program
News release from HHS.gov: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19
WEB ANNOUNCEMENTS
December 02, 2020
News release from HHS.gov: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19
BARDA is partnering with Chrysalis BioTherapeutics to continue development of TP508 as a nuclear countermeasure
WEB ANNOUNCEMENTS
November 30, 2020
BARDA is partnering with Chrysalis BioTherapeutics to continue development of TP508 as a nuclear countermeasure
BARDA partners with Siemens Healthineers to expedite development of a high-throughput, automated antigen test for COVID-19
WEB ANNOUNCEMENTS
November 24, 2020
BARDA partners with Siemens Healthineers to expedite development of a high-throughput, automated antigen test for COVID-19
News release from HHS.gov: HHS Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests
WEB ANNOUNCEMENTS
November 23, 2020
News release from HHS.gov: HHS Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests
BARDA Ventures
BLOGS/STORIES
November 19, 2020
BARDA Ventures
BARDA's Reflections on Antibiotic Resistance and the Path Forward
BLOGS/STORIES
November 18, 2020
BARDA's Reflections on Antibiotic Resistance and the Path Forward
BARDA expands partnership with DiaSorin Inc to develop an enhanced IgG assay for determining COVID-19 patient exposure and immune status
WEB ANNOUNCEMENTS
November 16, 2020
BARDA expands partnership with DiaSorin Inc to develop an enhanced IgG assay for determining COVID-19 patient exposure and immune status
BARDA Ventures: Evolving Federal National Health Security Using Novel Venture Capital-Style Partnership
BLOGS/STORIES
November 12, 2020
BARDA Ventures: Evolving Federal National Health Security Using Novel Venture Capital-Style Partnership
BARDA seeks nonprofit partner for BARDA Ventures: Catalyzing the 21st Century Cures Act and launching a new way to do business with HHS
WEB ANNOUNCEMENTS
November 10, 2020
BARDA seeks nonprofit partner for BARDA Ventures: Catalyzing the 21st Century Cures Act and launching a new way to do business with HHS
BARDA and JPEO-CBRND help Humanigen evaluate drug to potentially prevent or treat cytokine storm caused by COVID-19
WEB ANNOUNCEMENTS
November 06, 2020
BARDA and JPEO-CBRND help Humanigen evaluate drug to potentially prevent or treat cytokine storm caused by COVID-19
BARDA and Mesa Biotech collaborate on rapid diagnostics to distinguish coronavirus from influenza infections
WEB ANNOUNCEMENTS
November 06, 2020
BARDA and Mesa Biotech collaborate on rapid diagnostics to distinguish coronavirus from influenza infections
Message from the Acting BARDA Director: 2020 BARDA Industry Week Wrap Up
WEB ANNOUNCEMENTS
November 06, 2020
Message from the Acting BARDA Director: 2020 BARDA Industry Week Wrap Up
News release from HHS.gov: HHS and DOD announce $12.7 million contract with InBios International to boost U.S. production of rapid COVID-19 tests
WEB ANNOUNCEMENTS
November 02, 2020
News release from HHS.gov: HHS and DOD announce $12.7 million contract with InBios International to boost U.S. production of rapid COVID-19 tests
News release from HHS.gov: HHS and DOD Announce $119 Million Contract to Hologic to Better Meet the Demand of COVID-19 Testing
WEB ANNOUNCEMENTS
November 02, 2020
News release from HHS.gov: HHS and DOD Announce $119 Million Contract to Hologic to Better Meet the Demand of COVID-19 Testing
HHS, BARDA partner with Hologic to expedite development of a high-throughput, automated multiplex SARS-CoV-2/Flu assay
WEB ANNOUNCEMENTS
October 29, 2020
HHS, BARDA partner with Hologic to expedite development of a high-throughput, automated multiplex SARS-CoV-2/Flu assay
BARDA seeks abstract submissions for medical countermeasure development through the DRIVe ReDIRECT Program
WEB ANNOUNCEMENTS
October 28, 2020
BARDA seeks abstract submissions for medical countermeasure development through the DRIVe ReDIRECT Program
HHS, DOD Collaborate on Plans to Purchase Lilly Investigational Therapeutic to Treat COVID-19
WEB ANNOUNCEMENTS
October 28, 2020
HHS, DOD Collaborate on Plans to Purchase Lilly Investigational Therapeutic to Treat COVID-19
VIDEOS
October 27, 2020
BARDA Industry Day 2020 Presentations
More than 50 Million BARDA-Supported COVID-19 Diagnostic Tests Shipped to Communities across the US
BLOGS/STORIES
October 23, 2020
More than 50 Million BARDA-Supported COVID-19 Diagnostic Tests Shipped to Communities across the US
BARDA engaged Technical Resources International, Inc. (TRI), part of BARDA’s medical countermeasures clinical studies network, to support a large clinical trial as part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative
WEB ANNOUNCEMENTS
October 19, 2020
BARDA engaged Technical Resources International, Inc. (TRI), part of BARDA’s medical countermeasures clinical studies network, to support a large clinical trial as part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative
BARDA Awards Medical Countermeasures Clinical Studies Network
WEB ANNOUNCEMENTS
October 19, 2020
BARDA Awards Medical Countermeasures Clinical Studies Network
VIDEOS
October 17, 2020
Hear directly from the BARDA CBRN director, Dr. Chris Houchens, on his 2021 priorities. BARDA Industry Day 2020
BARDA and Beckman Coulter partner to aid in rapid detection of MIS-C, a pediatric complication of SARS-CoV-2 infection
WEB ANNOUNCEMENTS
October 15, 2020
BARDA and Beckman Coulter partner to aid in rapid detection of MIS-C, a pediatric complication of SARS-CoV-2 infection
VIDEOS
October 14, 2020
BioTalk Podcast: Catalyst Office
News Release from HHS.gov:  Trump Administration expands manufacturing capacity with Cytiva for components of COVID-19 vaccines
WEB ANNOUNCEMENTS
October 13, 2020
News Release from HHS.gov: Trump Administration expands manufacturing capacity with Cytiva for components of COVID-19 vaccines
VIDEOS
October 12, 2020
#MakingCountermeasures Series
Trump Administration expands collaboration with AstraZeneca to develop and manufacture an investigational monoclonal antibody to prevent COVID-19
WEB ANNOUNCEMENTS
October 09, 2020
Trump Administration expands collaboration with AstraZeneca to develop and manufacture an investigational monoclonal antibody to prevent COVID-19
BARDA and Current Health partner on remote monitoring to predict likelihood of hospitalization and need for ICU-level support in COVID-19 patients
WEB ANNOUNCEMENTS
October 07, 2020
BARDA and Current Health partner on remote monitoring to predict likelihood of hospitalization and need for ICU-level support in COVID-19 patients
BARDA and DOD JPEO-CBRND Collaborate with Cepheid on Single, Rapid Diagnostic Test to Detect COVID-19, Influenza and RSV
WEB ANNOUNCEMENTS
October 07, 2020
BARDA and DOD JPEO-CBRND Collaborate with Cepheid on Single, Rapid Diagnostic Test to Detect COVID-19, Influenza and RSV
HHS funds development of needle-free vaccine administration technology
WEB ANNOUNCEMENTS
October 06, 2020
HHS funds development of needle-free vaccine administration technology
BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin
WEB ANNOUNCEMENTS
October 05, 2020
BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin
Message from the Acting BARDA Director: Thank you for your support in FY2020
WEB ANNOUNCEMENTS
October 05, 2020
Message from the Acting BARDA Director: Thank you for your support in FY2020
Two novel investigational drugs targeting antibiotic-resistant infections move into advanced development with HHS support
WEB ANNOUNCEMENTS
September 30, 2020
Two novel investigational drugs targeting antibiotic-resistant infections move into advanced development with HHS support
BARDA partners with Invirsa to develop a treatment for ocular conditions associated with DNA damage, including sulfur mustard injury
WEB ANNOUNCEMENTS
September 29, 2020
BARDA partners with Invirsa to develop a treatment for ocular conditions associated with DNA damage, including sulfur mustard injury
BARDA awards additional funds to Basilea for next steps in antibiotic development to treat bloodstream infections caused by Staphylococcus aureus bacteria
WEB ANNOUNCEMENTS
September 28, 2020
BARDA awards additional funds to Basilea for next steps in antibiotic development to treat bloodstream infections caused by Staphylococcus aureus bacteria
BARDA and Luminex Corporation partner to expedite development of COVID-19 diagnostic test
WEB ANNOUNCEMENTS
September 24, 2020
BARDA and Luminex Corporation partner to expedite development of COVID-19 diagnostic test
BARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic
WEB ANNOUNCEMENTS
September 23, 2020
BARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic
Clinical Synergies of New Medical Countermeasures in Burn Care
BLOGS/STORIES
September 22, 2020
Clinical Synergies of New Medical Countermeasures in Burn Care
BARDA Partners with University of Pennsylvania Researchers to Develop a Lung-on-a-Chip for Discovery of Treatments for Chlorine Exposure
WEB ANNOUNCEMENTS
September 21, 2020
BARDA Partners with University of Pennsylvania Researchers to Develop a Lung-on-a-Chip for Discovery of Treatments for Chlorine Exposure
BARDA expanded partnership with Ortho Clinical Diagnostics to develop high-throughput, automated COVID-19 antigen and further advancements to antibody tests
WEB ANNOUNCEMENTS
September 18, 2020
BARDA expanded partnership with Ortho Clinical Diagnostics to develop high-throughput, automated COVID-19 antigen and further advancements to antibody tests
BARDA and JPEO-CBRND partner with Ology Bioservices to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
WEB ANNOUNCEMENTS
September 17, 2020
BARDA and JPEO-CBRND partner with Ology Bioservices to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
BARDA and Marinus Partner to Develop New Treatment for Refractory Seizures
WEB ANNOUNCEMENTS
September 14, 2020
BARDA and Marinus Partner to Develop New Treatment for Refractory Seizures
BARDA and 98point6 partner to accelerate COVID-19 program
WEB ANNOUNCEMENTS
September 11, 2020
BARDA and 98point6 partner to accelerate COVID-19 program
VIDEOS
September 02, 2020
PODCAST Season 3 Episode 26 - Public-Private Partnerships in Health Innovation
BARDA collaborates with NOWDiagnostics, Inc. to develop a rapid, point-of-care (POC) and over-the-counter (OTC), in vitro diagnostic test to detect antibodies against SARS-CoV-2
WEB ANNOUNCEMENTS
August 31, 2020
BARDA collaborates with NOWDiagnostics, Inc. to develop a rapid, point-of-care (POC) and over-the-counter (OTC), in vitro diagnostic test to detect antibodies against SARS-CoV-2
VIDEOS
August 31, 2020
BARDA's COVID-19 Medical Countermeasure Investments
BARDA establishes four new partnerships to explore innovative vaccine delivery technologies
WEB ANNOUNCEMENTS
August 26, 2020
BARDA establishes four new partnerships to explore innovative vaccine delivery technologies
Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine
WEB ANNOUNCEMENTS
August 11, 2020
Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine
BARDA and JPEO-CBRND partner with Grand River Aseptic Manufacturing to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
WEB ANNOUNCEMENTS
August 06, 2020
BARDA and JPEO-CBRND partner with Grand River Aseptic Manufacturing to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed
BARDA supports a second COVID-19 antibody test by DiaSorin, Inc.
WEB ANNOUNCEMENTS
August 06, 2020
BARDA supports a second COVID-19 antibody test by DiaSorin, Inc.
HHS, DOD collaborate with Johnson & Johnson to produce millions of COVID-19 investigational vaccine doses
WEB ANNOUNCEMENTS
August 05, 2020
HHS, DOD collaborate with Johnson & Johnson to produce millions of COVID-19 investigational vaccine doses
Now Accepting Applications for BARDA Industry Day Lightning Talks
WEB ANNOUNCEMENTS
August 03, 2020
Now Accepting Applications for BARDA Industry Day Lightning Talks
BARDA Industry Day 2020
EVENTS/MEETINGS
August 01, 2020
BARDA Industry Day 2020
 HHS, DOD partner with Sanofi and GSK on commercial-scale manufacturing demonstration project to produce millions of COVID-19 investigational vaccine doses
WEB ANNOUNCEMENTS
July 31, 2020
HHS, DOD partner with Sanofi and GSK on commercial-scale manufacturing demonstration project to produce millions of COVID-19 investigational vaccine doses
BARDA continues to partner with Moderna for the first Phase 3 clinical trial of a COVID-19 vaccine to start in the United States
WEB ANNOUNCEMENTS
July 28, 2020
BARDA continues to partner with Moderna for the first Phase 3 clinical trial of a COVID-19 vaccine to start in the United States
HHS reserves and rapidly expands manufacturing capacity for COVID-19 vaccines at Texas Center for Innovation in Advanced Development and Manufacturing
WEB ANNOUNCEMENTS
July 27, 2020
HHS reserves and rapidly expands manufacturing capacity for COVID-19 vaccines at Texas Center for Innovation in Advanced Development and Manufacturing
U.S. government engages Pfizer to produce millions of doses of COVID-19 vaccine
WEB ANNOUNCEMENTS
July 22, 2020
U.S. government engages Pfizer to produce millions of doses of COVID-19 vaccine
BARDA Industry Day 2020: Lightning Talks Registration Coming Soon
WEB ANNOUNCEMENTS
July 15, 2020
BARDA Industry Day 2020: Lightning Talks Registration Coming Soon
BARDA and JPEO-CBRND form partnership with Smiths Medical to expand domestic manufacturing capacity for safety needles and syringes
WEB ANNOUNCEMENTS
July 15, 2020
BARDA and JPEO-CBRND form partnership with Smiths Medical to expand domestic manufacturing capacity for safety needles and syringes
BARDA and JPEO-CBRND work with Retractable Technologies, Inc. to expand manufacturing of needles and syringes in the US
WEB ANNOUNCEMENTS
July 09, 2020
BARDA and JPEO-CBRND work with Retractable Technologies, Inc. to expand manufacturing of needles and syringes in the US
BARDA and JPEO-CBRND establish partnership with Becton Dickinson to expand domestic manufacturing capacity for needles and syringes
WEB ANNOUNCEMENTS
July 09, 2020
BARDA and JPEO-CBRND establish partnership with Becton Dickinson to expand domestic manufacturing capacity for needles and syringes
 BARDA and DoD work with SiO2 Materials Science to increase domestic manufacturing of vials
WEB ANNOUNCEMENTS
July 07, 2020
BARDA and DoD work with SiO2 Materials Science to increase domestic manufacturing of vials
HHS, DOD collaborate with Novavax to produce millions of COVID-19 investigational vaccine doses in commercial-scale manufacturing demonstration project
WEB ANNOUNCEMENTS
July 07, 2020
HHS, DOD collaborate with Novavax to produce millions of COVID-19 investigational vaccine doses in commercial-scale manufacturing demonstration project
HHS, DOD collaborate with Regeneron on large-scale manufacturing demonstration project of COVID-19 investigational therapeutic treatmen
WEB ANNOUNCEMENTS
July 07, 2020
HHS, DOD collaborate with Regeneron on large-scale manufacturing demonstration project of COVID-19 investigational therapeutic treatmen
BARDA partners with Chembio Diagnostics, Inc. to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens
WEB ANNOUNCEMENTS
July 06, 2020
BARDA partners with Chembio Diagnostics, Inc. to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens
BARDA and Sonica Health expand partnership to develop wearable patch as an early monitoring platform for COVID-19 infection
WEB ANNOUNCEMENTS
July 01, 2020
BARDA and Sonica Health expand partnership to develop wearable patch as an early monitoring platform for COVID-19 infection
BARDA Industry Day 2020:  Save the Date
WEB ANNOUNCEMENTS
July 01, 2020
BARDA Industry Day 2020: Save the Date
BARDA partners with Colorado State University’s Infectious Disease Research Center (IDRC) to further develop the SolaVAXTM platform to address COVID-19
WEB ANNOUNCEMENTS
June 25, 2020
BARDA partners with Colorado State University’s Infectious Disease Research Center (IDRC) to further develop the SolaVAXTM platform to address COVID-19
BARDA partners with MBio Diagnostics to develop an in vitro point-of-care serology test for the detection of human anti-SARS-CoV-2 antibodies from whole blood samples
WEB ANNOUNCEMENTS
June 23, 2020
BARDA partners with MBio Diagnostics to develop an in vitro point-of-care serology test for the detection of human anti-SARS-CoV-2 antibodies from whole blood samples
Why Sepsis Solutions Can Help COVID-19 Patients
BLOGS/STORIES
June 22, 2020
Why Sepsis Solutions Can Help COVID-19 Patients
BARDA Teams Up with DoD’s JPEO-CBRN and Corning Incorporated to Expand Production of Corning’s Valor ® Glass Vials
WEB ANNOUNCEMENTS
June 19, 2020
BARDA Teams Up with DoD’s JPEO-CBRN and Corning Incorporated to Expand Production of Corning’s Valor ® Glass Vials
BARDA & Empatica forge new partnership to develop an early monitoring platform to identify COVID-19 infection
WEB ANNOUNCEMENTS
June 19, 2020
BARDA & Empatica forge new partnership to develop an early monitoring platform to identify COVID-19 infection
BARDA supports development of two automated antibody tests for COVID-19 by Ortho Clinical Diagnostics
WEB ANNOUNCEMENTS
June 17, 2020
BARDA supports development of two automated antibody tests for COVID-19 by Ortho Clinical Diagnostics
BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients
WEB ANNOUNCEMENTS
June 16, 2020
BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients
FDA ends emergency use authorization (EUA) of hydroxychloroquine
WEB ANNOUNCEMENTS
June 15, 2020
FDA ends emergency use authorization (EUA) of hydroxychloroquine
BARDA funds two first-in-human studies for Regeneron’s COVID-19 antibody cocktail
WEB ANNOUNCEMENTS
June 15, 2020
BARDA funds two first-in-human studies for Regeneron’s COVID-19 antibody cocktail
BARDA DRIVe and Sepsis Alliance to provide educational content on COVID-19 and Sepsis
WEB ANNOUNCEMENTS
June 11, 2020
BARDA DRIVe and Sepsis Alliance to provide educational content on COVID-19 and Sepsis
BARDA, Snapdragon Chemistry Inc., demonstrate deployable domestic manufacturing technology for COVID-19 vaccine component
WEB ANNOUNCEMENTS
June 11, 2020
BARDA, Snapdragon Chemistry Inc., demonstrate deployable domestic manufacturing technology for COVID-19 vaccine component
BARDA, Chembio Diagnostics Partnership Results in FDA-Cleared Diagnostic Test for Zika
WEB ANNOUNCEMENTS
June 10, 2020
BARDA, Chembio Diagnostics Partnership Results in FDA-Cleared Diagnostic Test for Zika
Latest BARDA collaboration with OraSure Technologies Inc. aims to develop highly reliable, high-throughput diagnostic test for SARS-CoV-2 antibodies in oral fluids
WEB ANNOUNCEMENTS
June 10, 2020
Latest BARDA collaboration with OraSure Technologies Inc. aims to develop highly reliable, high-throughput diagnostic test for SARS-CoV-2 antibodies in oral fluids
BARDA, DARPA, and AstraZeneca Collaborate to Develop a Novel COVID-19 Therapeutic
WEB ANNOUNCEMENTS
June 09, 2020
BARDA, DARPA, and AstraZeneca Collaborate to Develop a Novel COVID-19 Therapeutic
BARDA engages Moderna to expand domestic manufacturing of the Moderna SARS-CoV-2 vaccine (mRNA-1273) to protect against COVID-19
WEB ANNOUNCEMENTS
June 05, 2020
BARDA engages Moderna to expand domestic manufacturing of the Moderna SARS-CoV-2 vaccine (mRNA-1273) to protect against COVID-19
BARDA partners with Evidation Health to identify COVID-19 infections more quickly in healthcare workers and first responders using self-monitoring and wearable devices
WEB ANNOUNCEMENTS
June 04, 2020
BARDA partners with Evidation Health to identify COVID-19 infections more quickly in healthcare workers and first responders using self-monitoring and wearable devices
BARDA partners with Quidel Corporation to develop one-hour, mobile-integrated multiplex test on Sofia platform to detect SARS-COV-2 plus three additional respiratory viruses
WEB ANNOUNCEMENTS
June 02, 2020
BARDA partners with Quidel Corporation to develop one-hour, mobile-integrated multiplex test on Sofia platform to detect SARS-COV-2 plus three additional respiratory viruses
BARDA announces partnership with Siemens Healthineers to develop automated total antibody test for COVID-19
WEB ANNOUNCEMENTS
June 02, 2020
BARDA announces partnership with Siemens Healthineers to develop automated total antibody test for COVID-19
BARDA and Genentech expand partnership to begin Phase 2 clinical trial to evaluate investigational treatments for COVID-19 patients
WEB ANNOUNCEMENTS
June 01, 2020
BARDA and Genentech expand partnership to begin Phase 2 clinical trial to evaluate investigational treatments for COVID-19 patients
HHS Adds $628 Million to Contract with Emergent BioSolutions to Secure Manufacturing Capacity for Operation Warp Speed
WEB ANNOUNCEMENTS
June 01, 2020
HHS Adds $628 Million to Contract with Emergent BioSolutions to Secure Manufacturing Capacity for Operation Warp Speed
BARDA partners with Merck and IAVI to accelerate development of a vaccine to prevent COVID-19
WEB ANNOUNCEMENTS
May 26, 2020
BARDA partners with Merck and IAVI to accelerate development of a vaccine to prevent COVID-19
Trump Administration’s Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October
WEB ANNOUNCEMENTS
May 21, 2020
Trump Administration’s Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October
BARDA and VitalConnect partner to monitor nursing home and COVID-19 patients for early indication of patient deterioration
WEB ANNOUNCEMENTS
May 20, 2020
BARDA and VitalConnect partner to monitor nursing home and COVID-19 patients for early indication of patient deterioration
A Critical Time to be in Public Service: A Perspective from a Pair of Experienced Doctors Caring for COVID-19 Patients
BLOGS/STORIES
May 20, 2020
A Critical Time to be in Public Service: A Perspective from a Pair of Experienced Doctors Caring for COVID-19 Patients
HHS, industry partners expand U.S.-based pharmaceutical manufacturing for COVID-19 response
WEB ANNOUNCEMENTS
May 19, 2020
HHS, industry partners expand U.S.-based pharmaceutical manufacturing for COVID-19 response
BARDA announces expanded partnership with Beckman Coulter to assess digital sepsis prediction solution for COVID-19 patients
WEB ANNOUNCEMENTS
May 15, 2020
BARDA announces expanded partnership with Beckman Coulter to assess digital sepsis prediction solution for COVID-19 patients
Raising Awareness: Many Roads Lead to Sepsis, Even for COVID-19 Patients
BLOGS/STORIES
May 15, 2020
Raising Awareness: Many Roads Lead to Sepsis, Even for COVID-19 Patients
BARDA supports development of AI-based handheld ultrasound to triage trauma or lung injuries and disease diagnosis, including COVID-19
WEB ANNOUNCEMENTS
May 08, 2020
BARDA supports development of AI-based handheld ultrasound to triage trauma or lung injuries and disease diagnosis, including COVID-19
BARDA engages in a collaboration to support Mayo Clinic Expanded Access Program for use of convalescent plasma to hospitalized patients with COVID-19
WEB ANNOUNCEMENTS
May 04, 2020
BARDA engages in a collaboration to support Mayo Clinic Expanded Access Program for use of convalescent plasma to hospitalized patients with COVID-19
BARDA expands partnership with Hologic for development of a second high-throughput molecular assay for SARS-CoV-2
WEB ANNOUNCEMENTS
May 01, 2020
BARDA expands partnership with Hologic for development of a second high-throughput molecular assay for SARS-CoV-2
BARDA expands collaboration with Cerus Corporation to evaluate the INTERCEPT Blood System against SARS-CoV-2
WEB ANNOUNCEMENTS
April 28, 2020
BARDA expands collaboration with Cerus Corporation to evaluate the INTERCEPT Blood System against SARS-CoV-2
BARDA and InBios International, Inc. partner to expedite development for serological tests to identify asymptomatic or recovered cases of COVID-19
WEB ANNOUNCEMENTS
April 27, 2020
BARDA and InBios International, Inc. partner to expedite development for serological tests to identify asymptomatic or recovered cases of COVID-19
BARDA and America’s Blood Centers partner to support and coordinate collection and distribution of convalescent plasma units for COVID-19 patients’ therapeutic use
WEB ANNOUNCEMENTS
April 27, 2020
BARDA and America’s Blood Centers partner to support and coordinate collection and distribution of convalescent plasma units for COVID-19 patients’ therapeutic use
BARDA announces partnership expansion with Cytovale, Inc. for continued development of Cytovale’s rapid diagnostic system for sepsis as part of COVID-19 pandemic response
WEB ANNOUNCEMENTS
April 23, 2020
BARDA announces partnership expansion with Cytovale, Inc. for continued development of Cytovale’s rapid diagnostic system for sepsis as part of COVID-19 pandemic response
BARDA and Tangen Biosciences, Inc. entered into a public-private partnership to develop a rapid diagnostic test for SARS-CoV-2
WEB ANNOUNCEMENTS
April 20, 2020
BARDA and Tangen Biosciences, Inc. entered into a public-private partnership to develop a rapid diagnostic test for SARS-CoV-2
BARDA supports Hememics Biotechnologies, Inc to develop a rapid antigen and antibody diagnostic to identify current or past SARS-CoV-2 infections in 60 seconds
WEB ANNOUNCEMENTS
April 16, 2020
BARDA supports Hememics Biotechnologies, Inc to develop a rapid antigen and antibody diagnostic to identify current or past SARS-CoV-2 infections in 60 seconds
BARDA and American Red Cross collaborate on convalescent plasma for therapeutic use in COVID-19 infected patients
WEB ANNOUNCEMENTS
April 15, 2020
BARDA and American Red Cross collaborate on convalescent plasma for therapeutic use in COVID-19 infected patients
BARDA and Sanofi prepare for studies of COVID-19 vaccine
WEB ANNOUNCEMENTS
April 15, 2020
BARDA and Sanofi prepare for studies of COVID-19 vaccine
BARDA and Vela Diagnostics USA, Inc. entered into a public-private partnership to develop a rapid diagnostic test for the COVID-19 pandemic
WEB ANNOUNCEMENTS
April 14, 2020
BARDA and Vela Diagnostics USA, Inc. entered into a public-private partnership to develop a rapid diagnostic test for the COVID-19 pandemic
HHS facilitates development of immunotherapies for COVID-19 patients
WEB ANNOUNCEMENTS
April 13, 2020
HHS facilitates development of immunotherapies for COVID-19 patients
HHS/BARDA supports DiaSorin, Inc to develop a fully automated serology test to detect novel coronavirus infections
WEB ANNOUNCEMENTS
April 13, 2020
HHS/BARDA supports DiaSorin, Inc to develop a fully automated serology test to detect novel coronavirus infections
HHS supports Nanomix, Inc to develop a rapid mobile diagnostic test to detect presence of current or past COVID-19 infection in patients
WEB ANNOUNCEMENTS
April 08, 2020
HHS supports Nanomix, Inc to develop a rapid mobile diagnostic test to detect presence of current or past COVID-19 infection in patients
HHS, Department of Defense, and Grifols Collaborate to Develop Plasma-based Treatment for COVID-19
WEB ANNOUNCEMENTS
April 07, 2020
HHS, Department of Defense, and Grifols Collaborate to Develop Plasma-based Treatment for COVID-19
BARDA leverages CIADM Partner for Development of Plasma-based Therapeutic Treatment for COVID-19
WEB ANNOUNCEMENTS
April 07, 2020
BARDA leverages CIADM Partner for Development of Plasma-based Therapeutic Treatment for COVID-19
BARDA and Genentech collaborate to accelerate clinical trial of a novel COVID-19 therapeutic treatment
WEB ANNOUNCEMENTS
April 07, 2020
BARDA and Genentech collaborate to accelerate clinical trial of a novel COVID-19 therapeutic treatment
HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients
WEB ANNOUNCEMENTS
April 06, 2020
HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients
BARDA is partnering with OraSure Technologies Inc. to develop first rapid at-home COVID-19 diagnostic test
WEB ANNOUNCEMENTS
April 06, 2020
BARDA is partnering with OraSure Technologies Inc. to develop first rapid at-home COVID-19 diagnostic test
BARDA, Department of Defense, and SAb Biotherapeutics to Partner to Develop a Novel COVID-19 Therapeutic
WEB ANNOUNCEMENTS
April 01, 2020
BARDA, Department of Defense, and SAb Biotherapeutics to Partner to Develop a Novel COVID-19 Therapeutic
BARDA Collaborates with GenMark Dx on a Rapid Diagnostic Test to Detect COVID-19
WEB ANNOUNCEMENTS
April 01, 2020
BARDA Collaborates with GenMark Dx on a Rapid Diagnostic Test to Detect COVID-19
BARDA Supports Luminex Corporation Development of a Second Diagnostic Test to Detect Novel Coronavirus Infections
WEB ANNOUNCEMENTS
April 01, 2020
BARDA Supports Luminex Corporation Development of a Second Diagnostic Test to Detect Novel Coronavirus Infections
HHS expands partnership with Janssen to develop coronavirus therapeutics
WEB ANNOUNCEMENTS
March 31, 2020
HHS expands partnership with Janssen to develop coronavirus therapeutics
HHS engages Moderna’s mRNA technology to accelerate development of a COVID-19 vaccine
WEB ANNOUNCEMENTS
March 31, 2020
HHS engages Moderna’s mRNA technology to accelerate development of a COVID-19 vaccine
Janssen Research and Development partner with BARDA to accelerate clinical trials and manufacturing of COVID-19 vaccine
WEB ANNOUNCEMENTS
March 31, 2020
Janssen Research and Development partner with BARDA to accelerate clinical trials and manufacturing of COVID-19 vaccine
Cue Health partners with BARDA for the development of a rapid, point-of-care SARS-CoV-2 Test
WEB ANNOUNCEMENTS
March 31, 2020
Cue Health partners with BARDA for the development of a rapid, point-of-care SARS-CoV-2 Test
BARDA and Luminex Corporation Partner to Expedite Development and EUA Clearance for COVID-19 Diagnostic Test
WEB ANNOUNCEMENTS
March 31, 2020
BARDA and Luminex Corporation Partner to Expedite Development and EUA Clearance for COVID-19 Diagnostic Test
HHS, DoD collaborate with Cepheid on rapid diagnostics to detect coronavirus infections
WEB ANNOUNCEMENTS
March 22, 2020
HHS, DoD collaborate with Cepheid on rapid diagnostics to detect coronavirus infections
HHS, DoD collaborate with Mesa Biotech on rapid diagnostics to detect coronavirus infections
WEB ANNOUNCEMENTS
March 20, 2020
HHS, DoD collaborate with Mesa Biotech on rapid diagnostics to detect coronavirus infections
BARDA partners with Qiagen to develop a rapid COVID-19 diagnostic test
WEB ANNOUNCEMENTS
March 20, 2020
BARDA partners with Qiagen to develop a rapid COVID-19 diagnostic test
HHS collaborates with DiaSorin Molecular to develop a COVID-19 diagnostic test
WEB ANNOUNCEMENTS
March 20, 2020
HHS collaborates with DiaSorin Molecular to develop a COVID-19 diagnostic test
HHS funds development of COVID-19 diagnostic tests
WEB ANNOUNCEMENTS
March 13, 2020
HHS funds development of COVID-19 diagnostic tests
 HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test; SARS-CoV-2; EZ-BAA
WEB ANNOUNCEMENTS
March 09, 2020
HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test; SARS-CoV-2; EZ-BAA
HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test
WEB ANNOUNCEMENTS
March 09, 2020
HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test
BARDA Leverages Strong Public-Private Partnerships to Spur a Rapid Response to the Novel Coronavirus Outbreak
BLOGS/STORIES
February 22, 2020
BARDA Leverages Strong Public-Private Partnerships to Spur a Rapid Response to the Novel Coronavirus Outbreak
HHS Engages Sanofi’s Recombinant Technology for 2019 Novel Coronavirus Vaccine
WEB ANNOUNCEMENTS
February 18, 2020
HHS Engages Sanofi’s Recombinant Technology for 2019 Novel Coronavirus Vaccine
HHS, Janssen Collaborate To Develop Coronavirus Therapeutics
WEB ANNOUNCEMENTS
February 18, 2020
HHS, Janssen Collaborate To Develop Coronavirus Therapeutics
Sepsis is Skyrocketing in the Medicare Population
BLOGS/STORIES
February 15, 2020
Sepsis is Skyrocketing in the Medicare Population
HHS, Janssen Join Forces On Coronavirus Vaccine
WEB ANNOUNCEMENTS
February 11, 2020
HHS, Janssen Join Forces On Coronavirus Vaccine
HHS Seeks Abstract Submissions for 2019-nCoV Diagnostics Development
WEB ANNOUNCEMENTS
February 05, 2020
HHS Seeks Abstract Submissions for 2019-nCoV Diagnostics Development
HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment
WEB ANNOUNCEMENTS
February 04, 2020
HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment
New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security
WEB ANNOUNCEMENTS
February 03, 2020
New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security
New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security
BLOGS/STORIES
February 03, 2020
New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security
Secretary Azar Declares Public Health Emergency for United States for 2019 Novel Coronavirus
WEB ANNOUNCEMENTS
January 31, 2020
Secretary Azar Declares Public Health Emergency for United States for 2019 Novel Coronavirus
BARDA COVID-19 Market Research
WEB ANNOUNCEMENTS
January 30, 2020
BARDA COVID-19 Market Research
2019 Novel Coronavirus Stakeholder Listening Session
WEB ANNOUNCEMENTS
January 29, 2020
2019 Novel Coronavirus Stakeholder Listening Session
The Skyrocketing Need for Speed: Partnering to Develop Rapid Diagnostic Tests That Protect Patients From Antibiotic Resistant Infections During Disasters and Every Day
BLOGS/STORIES
January 08, 2020
The Skyrocketing Need for Speed: Partnering to Develop Rapid Diagnostic Tests That Protect Patients From Antibiotic Resistant Infections During Disasters and Every Day
The Health Security Threat in My Backyard: How My Garden Proved That the US Needs More, Rapid, Diagnostics for Antimicrobial Resistant Infections
BLOGS/STORIES
December 17, 2019
The Health Security Threat in My Backyard: How My Garden Proved That the US Needs More, Rapid, Diagnostics for Antimicrobial Resistant Infections
The Power of Partnership: BARDA Ushers in 50th FDA-Approved Product for Health Security
BLOGS/STORIES
October 11, 2019
The Power of Partnership: BARDA Ushers in 50th FDA-Approved Product for Health Security
A Close Encounter of the Worst Kind: Sepsis
BLOGS/STORIES
September 18, 2019
A Close Encounter of the Worst Kind: Sepsis
Crossing the Finish Line: Project BioShield is Transforming the Nation's Health Security with Cutting-Edge Innovation, Sound Investments, and Strong Partnerships
BLOGS/STORIES
August 07, 2019
Crossing the Finish Line: Project BioShield is Transforming the Nation's Health Security with Cutting-Edge Innovation, Sound Investments, and Strong Partnerships
BARDA Industry Day 2019
EVENTS/MEETINGS
August 05, 2019
BARDA Industry Day 2019
Novel Partnerships, Payment Shifts, and Emerging US Leadership for Antimicrobial Drugs
BLOGS/STORIES
August 05, 2019
Novel Partnerships, Payment Shifts, and Emerging US Leadership for Antimicrobial Drugs
Building a Better Pipeline of Candidate Products for Project BioShield
BLOGS/STORIES
July 31, 2019
Building a Better Pipeline of Candidate Products for Project BioShield
Fifteen Years, Fifteen Stockpiled Countermeasures: Leveraging Project BioShield to Build an Unprecedented Array of Drugs, Vaccines, Therpeutics, and More to Enhance Health Security
BLOGS/STORIES
July 24, 2019
Fifteen Years, Fifteen Stockpiled Countermeasures: Leveraging Project BioShield to Build an Unprecedented Array of Drugs, Vaccines, Therpeutics, and More to Enhance Health Security
VIDEOS
July 24, 2019
Project BioShield: Partnering to Build a Portfolio of Medical Countermeasures
BARDA-Supported Zika Virus Test Receives FDA Clearance; Ready for Clinical Laboratory Use
BLOGS/STORIES
June 06, 2019
BARDA-Supported Zika Virus Test Receives FDA Clearance; Ready for Clinical Laboratory Use
A Critical Crash Course in Chemical Decontamination
BLOGS/STORIES
May 24, 2019
A Critical Crash Course in Chemical Decontamination
Project BioShield: Enhancing Preparedness, Ensuring Treatment Options
BLOGS/STORIES
May 13, 2019
Project BioShield: Enhancing Preparedness, Ensuring Treatment Options
VIDEOS
January 27, 2019
CARB-X to DRIVe: Building Novel Public Private Partnership to Foster Disruptive Innovation
Pandemic Influenza Vaccine: An Investmet in Preparedness that Lasts More Than a Decade
BLOGS/STORIES
December 13, 2018
Pandemic Influenza Vaccine: An Investmet in Preparedness that Lasts More Than a Decade
FDA Approval of Anti-Seizure Drug Provides a New Tool for Protecting Americans During a Chemical Attack
BLOGS/STORIES
October 31, 2018
FDA Approval of Anti-Seizure Drug Provides a New Tool for Protecting Americans During a Chemical Attack
BARDA and Its Partners Bring New Ammunition to the Battle Against Superbugs
BLOGS/STORIES
August 27, 2018
BARDA and Its Partners Bring New Ammunition to the Battle Against Superbugs
BARDA Industry Day 2018
EVENTS/MEETINGS
July 22, 2018
BARDA Industry Day 2018
New Smallpox Antiviral Increases Health Security
BLOGS/STORIES
July 13, 2018
New Smallpox Antiviral Increases Health Security
VIDEOS
June 06, 2018
Introducing DRIVe
From 1918 to 2018: BARDA's Role in the Evolution of Pandemic Preparedness
BLOGS/STORIES
May 21, 2018
From 1918 to 2018: BARDA's Role in the Evolution of Pandemic Preparedness
Decontamination Decoded: Disrobing, Dry Wiping Removes 99% of Chemical Decontaminants
BLOGS/STORIES
April 11, 2018
Decontamination Decoded: Disrobing, Dry Wiping Removes 99% of Chemical Decontaminants
BARDA Supports a Rapid, Deployable, Sensitive Diagnostic Platform to Diagnose Anthrax
BLOGS/STORIES
November 20, 2017
BARDA Supports a Rapid, Deployable, Sensitive Diagnostic Platform to Diagnose Anthrax
VIDEOS
October 16, 2017
Beyond The Lab: Kristen Herring, PhD
BARDA Adds New Antibiotic to Treat Drug-Resistant Bacterial Infections in Order to Protect the American Public
BLOGS/STORIES
August 30, 2017
BARDA Adds New Antibiotic to Treat Drug-Resistant Bacterial Infections in Order to Protect the American Public
New Frontiers and Extreme Environments: BARDA and NASA Join Forces to Better Protect the American Public and Astronauts from Radiation Injury
BLOGS/STORIES
August 02, 2017
New Frontiers and Extreme Environments: BARDA and NASA Join Forces to Better Protect the American Public and Astronauts from Radiation Injury
BARDA Industry Day 2017
EVENTS/MEETINGS
July 22, 2017
BARDA Industry Day 2017
Powering the Next Generation of Antibacterial Innovation to Enhance National Security
BLOGS/STORIES
March 30, 2017
Powering the Next Generation of Antibacterial Innovation to Enhance National Security
Next-Generation Burn Care Products and Strategies Draw on Innovative Ideas
BLOGS/STORIES
February 06, 2017
Next-Generation Burn Care Products and Strategies Draw on Innovative Ideas
BARDA-Supported Zika Vaccine Candidate Enters Clinical Trial
BLOGS/STORIES
January 09, 2017
BARDA-Supported Zika Vaccine Candidate Enters Clinical Trial
Better Preparing for Future Ebola Outbreaks Globally
BLOGS/STORIES
October 13, 2016
Better Preparing for Future Ebola Outbreaks Globally
BARDA Industry Day 2016
EVENTS/MEETINGS
July 22, 2016
BARDA Industry Day 2016
HHS Summit to Accelerate Zika Diagnostics Development
EVENTS/MEETINGS
July 15, 2016
HHS Summit to Accelerate Zika Diagnostics Development
Anticipating Threats, Investing in Solutions
BLOGS/STORIES
June 07, 2016
Anticipating Threats, Investing in Solutions
PHEMCE-Supported Drug Achieves FDA Approval
BLOGS/STORIES
March 21, 2016
PHEMCE-Supported Drug Achieves FDA Approval
Would Old Vaccine Work if Needed During a Pandemic?
BLOGS/STORIES
March 17, 2016
Would Old Vaccine Work if Needed During a Pandemic?
BARDA Seeks to Launch a Novel Partnership, a Product Accelerator to Address Antimicrobial Resistance
BLOGS/STORIES
February 19, 2016
BARDA Seeks to Launch a Novel Partnership, a Product Accelerator to Address Antimicrobial Resistance
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2016
EVENTS/MEETINGS
January 06, 2016
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2016
Better Protecting Our Nation Against Future Anthrax Attacks
BLOGS/STORIES
December 21, 2015
Better Protecting Our Nation Against Future Anthrax Attacks
Your Thanksgiving Bird Flu the Coop?
BLOGS/STORIES
November 25, 2015
Your Thanksgiving Bird Flu the Coop?
Fighting Antibiotic Resistance: The Long Road to New Solutions
BLOGS/STORIES
November 19, 2015
Fighting Antibiotic Resistance: The Long Road to New Solutions
JPM-MCS Industry Day : Proposed Other Transaction Agreement (OTA)
EVENTS/MEETINGS
November 02, 2015
JPM-MCS Industry Day : Proposed Other Transaction Agreement (OTA)
BARDA Industry Day 2015
EVENTS/MEETINGS
October 14, 2015
BARDA Industry Day 2015
Innovative Partnerships Support Antibiotic
BLOGS/STORIES
September 23, 2015
Innovative Partnerships Support Antibiotic
BARDA Continues Efforts to Make Ebola Therapeutics Available for Response
BLOGS/STORIES
February 24, 2015
BARDA Continues Efforts to Make Ebola Therapeutics Available for Response
Strong Partnerships are Helping Bring Next Generation Antibiotics to Market
BLOGS/STORIES
February 18, 2015
Strong Partnerships are Helping Bring Next Generation Antibiotics to Market
BARDA-Sponsored Flu Drug Earns FDA Approval
BLOGS/STORIES
December 23, 2014
BARDA-Sponsored Flu Drug Earns FDA Approval
Protecting Antibiotics by Strengthening the Antibiotic Pipeline
BLOGS/STORIES
November 25, 2014
Protecting Antibiotics by Strengthening the Antibiotic Pipeline
Developing an Ebola Therapeutic
BLOGS/STORIES
November 17, 2014
Developing an Ebola Therapeutic
BARDA Industry Day 2014
EVENTS/MEETINGS
October 15, 2014
BARDA Industry Day 2014
Using Innovative Business Models Enhance Antibiotic Development
BLOGS/STORIES
July 09, 2014
Using Innovative Business Models Enhance Antibiotic Development
BARDA Broad Spectrum Antimicrobials (BSA) Program
BLOGS/STORIES
June 24, 2014
BARDA Broad Spectrum Antimicrobials (BSA) Program
How is BARDA Positioned to Respond to the Threat?
BLOGS/STORIES
June 16, 2014
How is BARDA Positioned to Respond to the Threat?
What is Antibiotic Resistance and Why is it a Problem?
BLOGS/STORIES
June 10, 2014
What is Antibiotic Resistance and Why is it a Problem?
Changing the Landscape for Global Pandemic Influenza Vaccine Manufacturing
BLOGS/STORIES
February 13, 2014
Changing the Landscape for Global Pandemic Influenza Vaccine Manufacturing
Building and Sustaining a Robust Medical Countermeasures Pipeline
BLOGS/STORIES
December 06, 2013
Building and Sustaining a Robust Medical Countermeasures Pipeline
Award Winning Pandemic Influenza Preparedness
BLOGS/STORIES
November 13, 2013
Award Winning Pandemic Influenza Preparedness
BARDA Industry Day 2013
EVENTS/MEETINGS
November 12, 2013
BARDA Industry Day 2013
Planning to Keep the Nation Safe
BLOGS/STORIES
September 16, 2013
Planning to Keep the Nation Safe
BARDA Broad Agency Announcement Pre-Proposal Conference
EVENTS/MEETINGS
September 04, 2013
BARDA Broad Agency Announcement Pre-Proposal Conference
Can Rapid, Near-Patient Flu Tests Improve Public Health Preparedness and Response?
BLOGS/STORIES
December 13, 2012
Can Rapid, Near-Patient Flu Tests Improve Public Health Preparedness and Response?
BARDA Industry Day - Contracting for Countermeasures 2012
EVENTS/MEETINGS
December 12, 2012
BARDA Industry Day - Contracting for Countermeasures 2012
BARDA-NHLBI Blood Symposium
EVENTS/MEETINGS
November 15, 2012
BARDA-NHLBI Blood Symposium
The BARDA Multi-Broad Agency Announcement Pre-Proposal Conference 2012
EVENTS/MEETINGS
July 12, 2012
The BARDA Multi-Broad Agency Announcement Pre-Proposal Conference 2012
Boston BARDA Industry Day Contracting for Countermeasures
EVENTS/MEETINGS
October 17, 2011
Boston BARDA Industry Day Contracting for Countermeasures
5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
EVENTS/MEETINGS
February 10, 2011
5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
HHS PHEMCE Stakeholders Workshop 2009 and BARDA Industry Day
EVENTS/MEETINGS
December 02, 2009
HHS PHEMCE Stakeholders Workshop 2009 and BARDA Industry Day
CBRN Medical Countermeasures Workshop
EVENTS/MEETINGS
June 25, 2009
CBRN Medical Countermeasures Workshop
HHS PHEMCE Stakeholders Workshop 2008 and BARDA Industry Day
EVENTS/MEETINGS
September 24, 2008
HHS PHEMCE Stakeholders Workshop 2008 and BARDA Industry Day
2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day
EVENTS/MEETINGS
August 03, 2007
2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day
HHS PHEMC Enterprise Stakeholders Workshop
EVENTS/MEETINGS
July 31, 2007
HHS PHEMC Enterprise Stakeholders Workshop
BioShield Stakeholders Workshop
EVENTS/MEETINGS
October 24, 2006
BioShield Stakeholders Workshop
PRODUCTS
BARDA COVID-19 Medicalcountermeasure Products
PRODUCTS
BARDA Chemical, Biological, Radiological & Nuclear (CBRN) Products
PRODUCTS
BARDA DRIVe Products
PRODUCTS
BARDA DRIVe Sepsis Products
Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov